BMP6 expression was detected in the prostate tissue of over 50% of patients with clinically defined metastatic prostate adenocarcinoma, but was not detected in non-metastatic or benign prostate samples or in ocular melanoma tissue (Autzen et al., 1998). Here, BMP6 is linked to ocular melanoma.